Lifetime risk of diabetes among first nations and non-first nations people

CMAJ

Volumn 188, Issue 16, 2016, Pages 1147-1153

  Turin, Tanvir Chowdhury ^a,b   Saad, Nathalie ^a   Jun, Min ^a   Tonelli, Marcello ^a   Ma, Zhihai ^a   Barnabe, Cheryl Carmelle Marie ^a   Manns, Braden ^a,b   Hemmelgarn, Brenda ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CANADA; DIABETES MELLITUS; FEMALE; HUMAN; INCIDENCE; INDIGENOUS PEOPLE; LIFE EXPECTANCY; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION RESEARCH; PREGNANCY DIABETES MELLITUS; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; SEDENTARY LIFESTYLE; SEX DIFFERENCE; URBAN AREA; ADULT; AGED; AGING; ALBERTA; AMERICAN INDIAN; COHORT ANALYSIS; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNOLOGY; MIDDLE AGED; REGISTER; SEX RATIO; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AGING; ALBERTA; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84994049585     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.150787     Document Type: Article

References (57)

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
2. Zimmet P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-7.
3. Turin TC, Murakami Y, Miura K, et al. Diabetes and life expectancy among Japanese-NIPPON DATA80. Diabetes Res Clin Pract 2012;96:e18-22.
4. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033-46.
5. Johnson JA. Alberta diabetes atlas 2009. Edmonton: Institute of Health Economics; 2009.
6. Diabetes in Canada: facts and figures from a public health perspective. Ottawa: Public Health Agency of Canada; 2011. Available: www.phac-aspc.gc.ca/cd-mc/publications/diabetes-diabete/facts-figures-faits-chiffres-2011/index-eng.php (accessed 2014 Nov. 15).
7. Simpson SH, Corabian P, Jacobs P, et al. The cost of major comorbidity in people with diabetes mellitus. CMAJ 2003;168:1661-7.
8. First Nations & Inuit Health: diabetes. Ottawa: Health Canada; 2013. Available: www.hc-sc.gc.ca/fniah-spnia/diseases-maladies/diabete/index-eng.php (accessed 2014 Nov. 15).
9. Magliano DJ, Shaw JE, Shortreed SM, et al. Lifetime risk and projected population prevalence of diabetes. Diabetologia 2008; 51:2179-86.
10. Narayan KM, Boyle JP, Thompson TJ, et al. Effect of BMI on lifetime risk for diabetes in the US. Diabetes Care 2007;30:1562-6.
11. Narayan KM, Boyle JP, Thompson TJ, et al. Lifetime risk for diabetes mellitus in the United States. JAMA 2003;290:1884-90.
12. Population by selected ethnic origins, by province or territory (2006 census) (Canada). Ottawa: Statistics Canada; 2006.
13. Aboriginal peoples of Canada: First Nations people, Métis and Inuit. Ottawa: Statistics Canada; 2011. Available: www12.statcan. gc.ca/nhs-enm/2011/as-sa/99-011-x/99-011-x2011001-eng.cfm (accessed 2015 July 1).
14. Aboriginal peoples in Canada: First Nations people, Métis and Inuit: National Household Survey, 2011. Ottawa: Statistics Canada; 2013. Available: www12.statcan.gc.ca/nhs-enm/2011/as-sa/99-011-x/99-011-x2011001-eng.pdf (accessed 2016 Feb. 21).
15. Lachance N, Hossack N, Wijayasinghe C, et al. Health determinants for First Nations in Alberta. Ottawa: Health Canada; 2009. Available: http://publications.gc.ca/collections/collection-2011/sc-hc/H34-217-2010-eng.pdf (accessed 2016 Mar. 26).
16. Hux JE, Ivis F, Flintoft V, et al. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002;25:512-6.
17. Hemmelgarn BR, Clement F, Manns BJ, et al. Overview of the Alberta Kidney Disease Network. BMC Nephrol 2009;10:30.
18. Hemmelgarn BR, James MT, Manns BJ, et al. Rates of treated and untreated kidney failure in older vs younger adults. JAMA 2012;307:2507-15.
19. Quan H, Khan N, Hemmelgarn BR, et al.; Hypertension Outcome and Surveillance Team of the Canadian Hypertension Education Programs. Validation of a case definition to define hypertension using administrative data. Hypertension 2009;54:1423-8.
20. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9.
21. Beiser A, D'Agostino RB Sr, Seshadri S, et al. Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med 2000;19:1495-522.
22. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framinham Heart Study. JAMA 2002;287:1003-10.
23. Driver JA, Djoussé L, Logroscino G, et al. Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ 2008;337:a2467.
24. Dyck R, Osgood N, Lin TH, et al. Epidemiology of diabetes mellitus among First Nations and non-First Nations adults. CMAJ 2010;182:249-56.
25. Bruce SG, Riediger ND, Zacharias JM, et al. Obesity and obesity-related comorbidities in a Canadian First Nation population. Prev Chronic Dis 2011;8:A03.
26. Dyck R, Klomp H, Tan LK, et al. A comparison of rates, risk factors, and outcomes of gestational diabetes between aboriginal and non-aboriginal women in the Saskatoon health district. Diabetes Care 2002;25:487-93.
27. Martens PJ, Martin BD, O'Neil JD, et al. Diabetes and adverse outcomes in a First Nations population: associations with healthcare access, and socioeconomic and geographical factors. Can J Diabetes 2007;31:223-32.
28. Shah BR, Gunraj N, Hux JE. Markers of access to and quality of primary care for aboriginal people in Ontario, Canada. Am J Public Health 2003;93:798-802.
29. Green C, Blanchard JF, Young TK, et al. The epidemiology of diabetes in the Manitoba-registered First Nation population: current patterns and comparative trends. Diabetes Care 2003;26:1993-8.
30. Hemmelgarn BR, Toth EL, King M, et al. Diabetes in First Nations people. In: Johnson JA, editor. Alberta diabetes atlas 2007. Edmonton: Institute of Health Economics; 2007:127-40.
31. Hegele RA, Cao H, Hanley A, et al. Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians. Diabetes Care 2000;23:775-8.
32. Triggs-Raine BL, Kirkpatrick RD, Kelly SL, et al. HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proc Natl Acad Sci U S A 2002;99:4614-9.
33. Sellers EA, Triggs-Raine B, Rockman-Greenberg C, et al. The prevalence of the HNF-1α G319S mutation in Canadian aboriginal youth with type 2 diabetes. Diabetes Care 2002;25:2202-6.
34. Young TK, Reading J, Elias B. Type 2 diabetes mellitus in Canada's First Nations: status of an epidemic in progress. CMAJ 2000;163:561-6.
35. Young TK. The health of Native Americans: toward a biocultural epidemiology. New York: Oxford University Press; 1994: 145-68.
36. Ng C, Young TK, Corey PN. Associations of television viewing, physical activity and dietary behaviours with obesity in aboriginal and non-aboriginal Canadian youth. Public Health Nutr 2010;13:1430-7.
37. Lix LM, Bruce S, Sarkar J, et al. Risk factors and chronic conditions among Aboriginal and non-Aboriginal populations. Health Rep 2009;20:21-9.
38. Liu J, Young TK, Zinman B, et al. Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population. Obesity (Silver Spring) 2006; 14:500-8.
39. Pollex RL, Hanley AJ, Zinman B, et al. Metabolic syndrome in aboriginal Canadians: prevalence and genetic associations. Atherosclerosis 2006;184:121-9.
40. Gracey M, King M. Indigenous health part 1: determinants and disease patterns. Lancet 2009;374:65-75.
41. Ghosh H. Urban reality of type 2 diabetes among First Nations of eastern Ontario: western science and indigenous perceptions. J Global Citizenship Equity Educ 2012;2:158-81.
42. Ghosh H, Gomes J. Type 2 diabetes among Aboriginal peoples in Canada: a focus on direct and associated risk factors. Pimatisiwin 2011;9:245-75.
43. First Nations Regional Longitudinal Health Survey (RHS) 2002/03: results for adults, youths and children living in First Nations communities. Ottawa: First Nations Centre; 2005. Available: http://fnigc.ca/sites/default/files/ENpdf/RHS-2002/rhs2002-03-technical-report.pdf (accessed 2016 Feb. 21).
44. Turin TC, Kokubo Y, Murakami Y, et al. Lifetime risk of acute myocardial infarction in Japan. Circ Cardiovasc Qual Outcomes 2010;3:701-3.
45. Turin TC, Kokubo Y, Murakami Y, et al. Lifetime risk of stroke in Japan. Stroke 2010;41:1552-4.
46. Seshadri S, Beiser A, Kelly-Hayes M, et al. The lifetime risk of stroke. Stroke 2006;37:345-50.
47. Lloyd-Jones DM, Larson MG, Beiser A, et al. Lifetime risk of developing coronary heart disease. Lancet 1999;353:89-92.
48. Turin TC, Tonelli M, Manns BJ, et al. Lifetime risk of ESRD. J Am Soc Nephrol 2012;23:1569-78.
49. Edwards A, Elwyn G, Mulley A. Explaining risks: turning numerical data into meaningful pictures. BMJ 2002;324:827-30.
50. Schwartz LM, Woloshin S, Welch HG. Risk communication in clinical practice: putting cancer in context. J Natl Cancer Inst Monogr 1999;(25):124-33.
51. Fortin JM, Hirota LK, Bond BE, et al. Identifying patient preferences for communicating risk estimates: a descriptive pilot study. BMC Med Inform Decis Mak 2001;1:2.
52. Feuer EJ, Wun LM, Boring CC, et al. The lifetime risk of developing breast cancer. J Natl Cancer Inst 1993;85:892-7.
53. National Center for Health Statistics. Healthy people 2000 review, 1995-96. Hyattsville (MD): Public Health Service; 1996.
54. Seshadri S, Wolf P, Beiser A, et al. Lifetime risk of dementia and Alzheimer's disease. Neurology 1997;49:1498-504.
55. Turin TC, Hemmelgarn BR. Long-term risk projection and its application to nephrology research. J Nephrol 2012;25:441-9.
56. Turin TC, Rumana N, Okamura T. Residual lifetime risk of cardiovascular diseases in Japan. J Atheroscler Thromb 2011;18:443-7.
57. Cummings SR, Black DM, Rubin SM. Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. Arch Intern Med 1989;149:2445-8.